Risperidone is a remarkable antagonist of 5HT2A serotonin and dopamine receptor D2, and its lower doses can alleviate the negative effects of schizophrenia (Goodman & Gilman's, 2014). The gene discussed is DRD2; the disease is schizophrenia.